Spectrum of orocutaneous disease associations : Genodermatoses and inflammatory conditions - 27/12/17
Abstract |
The oral cavity and cutaneous organ systems share a close embryologic origin. Therefore, there are numerous dermatologic conditions presenting with concomitant oral findings of which the dermatologist must be aware. The second article in this continuing medical education series reviews inflammatory orocutaneous conditions and a number of genodermatoses. It is essential for dermatologists to be familiar with oral cavity manifestations associated with dermatologic diseases for prompt diagnosis, management, and appropriate referral to stomatology and dentistry.
Le texte complet de cet article est disponible en PDF.Key words : amyloidosis, Behcet disease, burning mouth syndrome, cutaneous manifestations, Darier disease, genodermatoses, inflammatory, lichen planus, nevoid basal cell carcinoma syndrome, oral cavity, orocutaneous diseases, Peutz-Jeghers syndrome, sarcoidosis, sclerosis complex, tuberous erythema multiforme
Plan
Funding sources: None. |
|
Dr Menter has served on the advisory board for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli-Lilly, Janssen Biotech, and LEO Pharma, been a consultant for AbbVie, Allergan, Amgen, Eli-Lilly, Galderma, Janssen Biotech, LEO Pharma, Novartis, and Pfizer, been an investigator for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Eli-Lilly, Janssen Biotech, LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron, and Syntrix, and has been a speaker for AbbVie, Amgen, Janssen Biotech, and LEO Pharma. Dr Menter has received grants from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Janssen Biotech, LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron, and Syntrix and has received honoraria from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli-Lilly, Galderma, Janssen Biotech, LEO Pharma, Novartis, and Pfizer. The other authors have no conflicts of interest to declare. |
|
Date of release: November 2017 |
|
Expiration date: November 2020 |
|
Reprints not available from the authors. |
Vol 77 - N° 5
P. 809-830 - novembre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?